 | Is it time for Americans to drop their infatuation with the PCR test? That’s what this COVID-19 testing expert thinks
msn.com - June 14 at 9:09 AM |
 | Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis
finance.yahoo.com - June 12 at 12:16 PM |
 | Twist Bioscience (NASDAQ:TWST) vs. Gilead Sciences (NASDAQ:GILD) Head-To-Head Comparison
americanbankingnews.com - June 12 at 7:10 AM |
| Gilead (GILD) Gets FDA Nod for Label Expansion of Epclusa
finance.yahoo.com - June 11 at 5:42 PM |
| Gilead’s Oral Epclusa Formulation Receives FDA Approval to Treat Hepatitis C in Children Aged 3 and Above
finance.yahoo.com - June 11 at 12:38 PM |
| 'Halftime Report' Traders Share Their Thoughts On Gilead, IBM And More
msn.com - June 10 at 8:08 PM |
| U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
finance.yahoo.com - June 10 at 8:08 PM |
 | GILD July 30th Options Begin Trading
nasdaq.com - June 10 at 3:08 PM |
|
| What's Behind This Wild-Card Coronavirus Stock?
finance.yahoo.com - June 8 at 7:45 AM |
| 'The time for talk is over' on health equity: HHS's Levine
finance.yahoo.com - June 7 at 5:49 PM |
 | The Petri Dish: Verily's new hire from FDA; Gilead's call to the Hill
bizjournals.com - June 4 at 9:38 PM |
| Noteworthy Friday Option Activity: GILD, VIAC, EA
nasdaq.com - June 4 at 9:38 PM |
 | Gilead Sciences, Inc Among Today’s Trending Stocks
forbes.com - June 4 at 12:31 PM |
| Trodelvy® Demonstrates Superior Outcomes to Standard of Care in Second-Line Treatment of Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT Study
finance.yahoo.com - June 4 at 11:37 AM |
| Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - June 4 at 8:20 AM |
| Helping provide the foundation
bizjournals.com - June 3 at 10:40 PM |
| Interesting GILD Put And Call Options For July 23rd
nasdaq.com - June 3 at 5:39 PM |
| Big pharma scoops up major office space in North Hills
bizjournals.com - June 3 at 7:38 AM |
| Russian court rejects U.S firm's lawsuit over COVID-19 drug remdesivir
msn.com - May 28 at 10:54 AM |
| UPDATE 1-Russian court rejects U.S firm's lawsuit over COVID-19 drug remdesivir
finance.yahoo.com - May 27 at 12:37 PM |
| New health-equity tracker launches for COVID-19 and beyond
finance.yahoo.com - May 26 at 9:31 AM |
| Russia ships remdesivir drug to India as part of humanitarian aid
finance.yahoo.com - May 25 at 2:48 PM |
| Can This Forgotten Coronavirus Stock Make You Rich?
finance.yahoo.com - May 25 at 2:48 PM |
| EU regulator backs extending approval for remdesivir for another year
nasdaq.com - May 21 at 1:35 PM |
| EMA backs renewing conditional marketing approval for remdesivir in COVID-19 patients
nasdaq.com - May 21 at 8:35 AM |
| This Top Healthcare Dividend Stock Is a Bargain Right Now
finance.yahoo.com - May 20 at 2:09 PM |
| GILD Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 4.2% Yield
nasdaq.com - May 20 at 9:09 AM |
| Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021
finance.yahoo.com - May 19 at 6:42 PM |
|
| Interesting GILD Put And Call Options For May 21st
nasdaq.com - May 17 at 1:40 PM |
| Notable Friday Option Activity: ELY, GILD, OLED
nasdaq.com - May 14 at 6:24 PM |
| See Which Of The Latest 13F Filers Holds Gilead Sciences
nasdaq.com - May 13 at 3:17 PM |
| Nasdaq 100 Movers: PDD, GILD
nasdaq.com - May 10 at 2:52 PM |
| Noteworthy Friday Option Activity: GILD, LVS, C
nasdaq.com - May 7 at 2:53 PM |
| CDC’s projection of U.S. COVID-19 surge is a ‘crystal ball’: Doctor
finance.yahoo.com - May 5 at 3:23 PM |
 | Gilead vs. Biogen: Which Biotech Stock is a Better Buy?
stocknews.com - May 5 at 12:41 PM |
 | Gilead Sciences: To Buy, Or Not To Buy - That Is The Question
seekingalpha.com - May 3 at 12:20 PM |
| Gilead Sciences, Inc. Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next
nasdaq.com - May 2 at 12:38 PM |
| Gilead Sciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
finance.yahoo.com - May 2 at 12:38 PM |
| Gilead's Q1 Results Show Just How Much the Biotech Is Relying on Its COVID Drug
finance.yahoo.com - April 30 at 7:54 AM |
 | Gilead Sciences (GILD) Q1 2021 Earnings Call Transcript
fool.com - April 30 at 12:45 AM |
| Gilead Sciences, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 29 at 9:19 PM |
 | Gilead Sciences Inc. Q1 adjusted earnings Miss Estimates
markets.businessinsider.com - April 29 at 8:49 PM |
| Gilead HIV, hepatitis C sales dip, shares down 2.3%
nasdaq.com - April 29 at 8:49 PM |
| Gilead Sciences Announces First Quarter 2021 Financial Results
finance.yahoo.com - April 29 at 8:49 PM |
| Gilead Sciences Announces Second Quarter 2021 Dividend
finance.yahoo.com - April 29 at 8:49 PM |
| Gilead stock falls as COVID-19 drug sales dwindle
finance.yahoo.com - April 29 at 8:49 PM |
| Gilead 1st-quarter profit rises despite lower HIV drug sales
finance.yahoo.com - April 29 at 8:49 PM |
| Gilead HIV, hepatitis C sales dip, shares down 2.6%
finance.yahoo.com - April 29 at 8:49 PM |
| UPDATE 2-Gilead HIV, hepatitis C sales dip, shares down 2.6%
finance.yahoo.com - April 29 at 8:49 PM |
| Gilead Stock Dives As Light HIV Drug Sales Lead To Quarterly Miss
finance.yahoo.com - April 29 at 8:49 PM |
